Navigation Links
Transcept Pharmaceuticals to Report First Quarter 2009 Results
Date:5/5/2009

RICHMOND, Calif., May 5 /PRNewswire-FirstCall/ -- Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT), a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience, today announced it will report results for its first quarter 2009 on Wednesday, May 13, 2009, after market close.

A conference call to review the results will begin at 5:00 p.m. ET (2:00 p.m. PT) on May 13, 2009 and will be hosted by Glenn A. Oclassen, President & Chief Executive Officer and Thomas P. Soloway, Senior Vice President & Chief Financial Officer.

To participate in the conference call, please dial 877-856-1965 (USA) or 719-325-4809 (International). In addition, a dial-up replay of the conference call will be available from May 13, 2009 at 8:00 p.m. ET (5:00 p.m. PT) through May 27, 2009. The replay telephone number is 888-203-1112 (USA) or 719-457-0820 (International), Replay Passcode: 4401678.

A live webcast of the call will also be available from the Investors section on the corporate web site at www.transcept.com. A webcast replay can be accessed on the corporate web site beginning May 13, 2009 at the same time as the conference call and will remain on the site through May 27, 2009.

About Transcept Pharmaceuticals

Transcept Pharmaceuticals is a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience. On January 30, 2009, Transcept completed a merger with Novacea, Inc. As part of the transaction, Novacea changed its name to "Transcept Pharmaceuticals, Inc." and its NASDAQ ticker symbol to "TSPT." The combined company res
'/>"/>

SOURCE Transcept Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Transcept Pharmaceuticals Announces Intent to Submit New Drug Application for Intermezzo(R) in Third Quarter 2008
2. Transcept Pharmaceuticals Submits New Drug Application for Intermezzo(R) for Treatment of Middle-of-the-Night Awakenings
3. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
4. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
5. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
6. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
7. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
8. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
9. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
10. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
11. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... Calif. , Nov. 26, 2014  Genomic Health, ... Kim Popovits , Chairman, Chief Executive Officer and President, ... Jaffray Healthcare Conference at The New York Palace Hotel ... December 3 at 11:30 am Eastern Time (ET). ... of the conference call, go to the  Investor Relations ...
(Date:11/26/2014)... , Nov. 26, 2014  Over 100 million ... those suffer from this pain daily. Chronic and acute ... pain management is born to fulfill the need for ... types of pain. On October 28th, a ... Cumberland, Maryland community.  This new ...
(Date:11/26/2014)... Oregon , November 26, 2014 ... fascia of the organ protrudes through the wall of a ... muscle area at birth are some of the causes of ... umbilical, hiatal, femoral, and incisional. An inguinal hernia is when ... An umbilical hernia is found in the area of the ...
Breaking Medicine Technology:Genomic Health to Present at the 26th Annual Piper Jaffray Healthcare Conference 2Genomic Health to Present at the 26th Annual Piper Jaffray Healthcare Conference 3New Pain Management Center Opens in Cumberland, Md. 2Global Hernia Repair Devices Market Size, Share, Trends and Forecast 2014 to 2018 - Big Market Research 2Global Hernia Repair Devices Market Size, Share, Trends and Forecast 2014 to 2018 - Big Market Research 3Global Hernia Repair Devices Market Size, Share, Trends and Forecast 2014 to 2018 - Big Market Research 4
... IRVINE, Calif., Feb. 15, 2011 Endologix, Inc. (Nasdaq: ... for aortic disorders, announced today the presentation of the ... 2011 iCON (International Congress of Endovascular Specialists) annual meeting ... Roll-In phase of the trial, technical success rates of ...
... 15, 2011 Daiichi Sankyo, Inc. (DSI), today announced ... Bethlehem Township, Pennsylvania from Amcor, a global packaging manufacturer. ... resources to more cost-effectively supplement its operations rather than ... be operational in the summer or early fall of ...
Cached Medicine Technology:Endologix Announces Presentation of Favorable Initial PEVAR Trial Results 2Endologix Announces Presentation of Favorable Initial PEVAR Trial Results 3Daiichi Sankyo, Inc. Acquires First US-Based Packaging and Manufacturing Facility 2
(Date:11/28/2014)... CA (PRWEB) November 28, 2014 ... on December 2, 2014. This national movement was created ... communities by giving to local charities and causes. ... Holiday, coincides with the kickoff of the holiday shopping ... is to shopping and Cyber Monday is to online ...
(Date:11/28/2014)... November 28, 2014 Dr. Diane Walder, ... , announced the addition of Dr. Bridgit Nolan to ... the practice after having completed her dermatology residency at ... Dr. Walder invited Dr. Nolan to join ... surgery and cosmetic dermatology. Not only does Dr. Nolan ...
(Date:11/28/2014)... Dr. Diane Walder, one of South Florida’s top ... practice called Ultrashape that is designed to help her patients ... six weeks. Ultrashape has been praised by patients as being ... compared to other types of external fat reduction. , “If ... Walder. , According to Dr. Walder, Ultrashape works by ...
(Date:11/28/2014)... Written and narrated by award winning author Dr. James ... Happiest Man In the World: Life Lessons From a Cultural ... Project C.U.R.E. came to be. , Raised in the Boise ... Richard W. Jackson, Dr. Jackson exceeded his goal of being ... he wasn’t happy. Prompted by this realization, James and his ...
(Date:11/28/2014)... (PRWEB) November 28, 2014 ... testing and treatment, helped employees learn their risk ... diabetes blood screening at a local school in ... @ Work initiative. , As the Presenting ... program , PreDiabetes Centers is co-hosting diabetes-prevention presentations ...
Breaking Medicine News(10 mins):Health News:Pathways Home Health & Hospice Joins #GivingTuesday; Annual Holiday Encourages Local Charitable Giving 2Health News:Pathways Home Health & Hospice Joins #GivingTuesday; Annual Holiday Encourages Local Charitable Giving 3Health News:Dr. Diane Walder Welcomes New Cosmetic Dermatologist to Practice 2Health News:Dr. Diane Walder Introduces New Fat Reduction Treatment Called Ultrashape 2Health News:Dr. Diane Walder Introduces New Fat Reduction Treatment Called Ultrashape 3Health News:Thanksgiving Weekend Audiobook Treat! “The Happiest Man In the World: Life Lessons From a Cultural Economist” by Dr. James W. Jackson 2Health News:PreDiabetes Centers Offers Workplace Diabetes Screening at Local School 2
... are testing a cancer-fighting film that could be applied ... which can be made into any size and shape, ... tumor site as it dissolves over several weeks. This ... ,A paper-thin, biodegradable implant is proving ...
... Biology online on February 8, have developed a small-molecule ... the control of cell division. The researchers show that ... mice and cancer-derived cells growing in culture. ... by two collaborating groups—one (Lenart et al.) led by ...
... to formulate rules on organ donations to foreigners. This ... ,Mr.Mundo emphasized on the need for such guidelines as ... flourishing in the country especially among the poorer sections of ... to set forth a list of guidelines has become necessary ...
... in the journal Blood, allogeneic stem cell transplants are ... ,An allogeneic stem cell transplant is a ... and lymphoma. The process of an allogeneic stem cell ... total body irradiation. These treatment approaches tend to kill ...
... therapy device may help people regain strength and normal ... to a University of California, Irvine study. ... ability to grasp and release objects after therapy sessions ... had at least moderate residual weakness and reduced function ...
... key inflammatory mediators (IL-12 and IL-23) is highly effective//, ... ,Current treatments for psoriasis include topical ... of the disease. Many of these treatments are messy, ... effective, according to Gerald Krueger, M.D., principal investigator for ...
Cached Medicine News:Health News:A Better Way to Deliver Cancer Drugs 2Health News:New Protein Inhibitor Halts Growth Of Cancerous Cells 2Health News:Allogeneic Stem Cell Transplants Linked With Risk for Diabetes and Hypertension 2Health News:Robotic Therapy Helps Restore Hand Use After Stroke 2Health News:Robotic Therapy Helps Restore Hand Use After Stroke 3Health News:New Treatment For Psoriasis Is Highly Effective 2
... Cobas Integra 400 plus, innovation means ... of reaction cuvettes and im-proved operator ... menu and ease-of-use required for true ... only possible with only one analytical ...
... The Advia 1650 has ... (as low as 2 L/test), ... 80 L/test) and water consumption ... management efficiency. Optional universal rack ...
Iron UIBC (UIBC Buffer + Color + Std.). An Automated analyzer test kits....
HDL Cholesterol, liquid....
Medicine Products: